4 hours Galectin Therapeutics (NASDAQ:GALT) Downgraded by StockNews.com MarketBeat
StockNews.com downgraded Galectin Therapeutics from a “hold” rating to a “sell” rating in a research note on Saturday.
StockNews.com downgraded Galectin Therapeutics from a “hold” rating to a “sell” rating in a research note on Saturday.